China Resources Medical Holdings Company Limited (1PH) — Capital Reinvestment Ratio
China Resources Medical Holdings Company Limited (1PH) has a Capital Reinvestment Ratio of 0.36x as of June 2023, meaning it reinvests 0% of its operating cash flow (€270.22 Million) in capital expenditures (€96.85 Million). See China Resources Medical Holdings Company (1PH) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
China Resources Medical Holdings Company Limited Capital Reinvestment Ratio (2016–2024)
This chart tracks China Resources Medical Holdings Company Limited's Capital Reinvestment Ratio across 9 annual periods.
Annual Capital Reinvestment Ratio for China Resources Medical Holdings Company Limited (2016–2024)
Year-by-year Capital Reinvestment Ratio for China Resources Medical Holdings Company Limited from 2016 to 2024. For live market cap and broader valuation context, see China Resources Medical Holdings Company market capitalisation.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.44x | €1.27 Billion | €563.69 Million | ▲ +9.0% |
| 2023 | 0.41x | €1.20 Billion | €486.68 Million | ▲ +0.9% |
| 2022 | 0.40x | €626.58 Million | €252.87 Million | ▲ +44.5% |
| 2021 | 0.28x | €710.43 Million | €198.43 Million | ▼ -14.2% |
| 2020 | 0.33x | €643.69 Million | €209.55 Million | ▲ +227.7% |
| 2019 | 0.10x | €366.05 Million | €36.37 Million | ▼ -42.4% |
| 2018 | 0.17x | €334.15 Million | €57.61 Million | ▲ +129.6% |
| 2017 | 0.08x | €459.54 Million | €34.50 Million | ▼ -60.4% |
| 2016 | 0.19x | €223.79 Million | €42.45 Million | — |